Results: At dialysis initiation, 59%, 31%, 9%, and 1.6% of patients met zero, one, two, or three guideline goals, respectively (total n ‫؍‬ 192,307). After multivariate adjustment, mortality hazard ratios (95% confidence intervals) were 0.81 (0.80 to 0.83) for patients who met one, 0.53 (0.51 to 0.56) for patients who met two, and 0.34 (0.30 to 0.39) for patients who met three guideline goals, compared with patients who met none. Meeting each individual goal was also associated with lower mortality.
T he number of patients with end-stage renal disease (ESRD) requiring dialysis is increasing (1, 2) . Patients with ESRD have exceedingly high morbidity and mortality rates, particularly in the first year after dialysis initiation, when mortality exceeds 25% (1) . To improve outcomes of patients with ESRD, the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) developed evidence-based guidelines for the care of kidney disease patients. For patients with chronic kidney disease (CKD) approaching ESRD, the KDOQI guidelines recommend timely nephrology referral, nutritional consultation, fistula placement for dialysis access, and control of anemia, acidosis, and mineral and bone metabolism parameters (3) . Evidence from prevalent dialysis patients (4) and from dialysis patients who survived on dialysis for at least 4 to 6 months (5,6) suggests that greater adherence to the KDOQI guidelines is associated with improved patient outcomes. Survival bias in these studies limits their generalizability to patients receiving renal replacement therapy who have survived beyond the initiation period. Whether guideline adherence at the time of dialysis initiation is associated with improved outcomes, particularly during the first year on dialysis, has not been examined.
We aimed to determine, in a large nationally representative cohort of incident hemodialysis patients, whether meeting a greater number of KDOQI guideline goals, specifically goals related to vascular access, anemia management, and serum albumin, at dialysis initiation is independently associated, in a graded manner, with survival during the first dialysis year.
Materials and Methods

Data Sources
This study used data from the United States Renal Data System (USRDS), a national data system that collects information on most new dialysis patients in the US from the Centers for Medicare & Medicaid Services (CMS). Information was obtained from the ESRD Medical Evidence Report (form CMS-2728), which is completed by providers for each new ESRD patient within 45 days of dialysis initiation. Data extracted included age, sex, race, primary cause of ESRD (diabetes, hypertension, glomerulonephritis, other), body mass index, comorbid conditions (heart failure, atherosclerotic heart disease, peripheral vascular disease, cerebrovascular disease, diabetes, hypertension, chronic obstructive pulmonary disease, cancer), smoking status, alcohol intake, drug use, inability to ambulate or transfer, need for help with activities of daily living, institutionalization status (nursing home residence), and insurance (Medicare, private insurance, Medicaid, Medicare and Medicaid, Veterans Administration, none, other). Pre-ESRD nephrology care was ascertained from question 18b on form CMS-2728: "Before ESRD was patient under care of a nephrologist?" If yes, and if the duration Ͼ12 months was chosen, the patient was defined as having received nephrology care for Ͼ12 months before ESRD. If yes, and if the duration 6 to 12 months or neither duration was chosen, the patient was defined as having received nephrology care for 0 to 12 months before ESRD. Similar assumptions were made to define duration of dietitian care based on question 18c: "Before ESRD was patient under care of kidney dietitian?"
Patients
We assembled a cohort of patients aged 20 years and older who initiated hemodialysis between June 1, 2005, and May 31, 2007, in the US. Patients who returned to hemodialysis from another renal replacement therapy modality, or who changed dialysis modality, underwent kidney transplant, or recovered kidney function within 60 days of their first ESRD service date were excluded from the analysis.
Meeting Guideline Goals
Data used to determine guideline adherence at dialysis initiation were obtained from form CMS-2728. Dialysis access information was obtained from question 18d: "What access was used on first outpatient dialysis? If not arteriovenous (AV) fistula: Is maturing AV fistula present? Is maturing AV graft present?" Hemoglobin and albumin values were obtained within 45 days before the first dialysis treatment.
The primary independent variable was number of guideline goals (zero, one, two, or three) met at dialysis initiation. The guideline goals examined in the analysis were: (1) use of AV fistula or graft at initiation; (2) hemoglobin Ն 11 g/dl; and (3) serum albumin Ն 4.0 g/dl when the method of measurement was bromcresol green or unspecified or Ն3.7g/dl when the method of measurement was bromcresol purple.
Follow-Up
Follow-up began on the first dialysis date and continued for up to 365 days. Follow-up was censored at modality change (to peritoneal dialysis or home dialysis), transplantation, or recovery of kidney function. Death information was obtained from the Death Notification (form CMS-2746); this information has been shown to be accurate in 99.5% of cases (7) .
Statistical Analyses
Baseline characteristics were compared between groups defined by the number of guideline goals met at dialysis initiation using ANOVA for continuous variables and the Chi-square test for categorical variables. Logistic regression analyses were performed to identify independent associations between study variables and meeting individual guideline goals. Kaplan-Meier curves of cumulative survival for groups that met each guideline goal, and number of guideline goals met (zero to three), were plotted and compared using the log rank test. Cox regression analysis was used to compare survival times adjusting for baseline sociodemographic characteristics, smoking status, alcohol intake and drug use, functional status parameters, and comorbid conditions as collected on form CMS-2728. All analyses were performed using version 9.1 SAS software. Estimated P values are reported without adjustment for making multiple comparisons. 
Results
Overall
Baseline Patient Characteristics
Of the 192,307 patients included in the cohort, 65% were white, 30% were African American, 44% were women, 46% had ESRD secondary to diabetes, and 25% had private insurance ( Table 1 ). The cohort primarily consisted of elderly patients; mean age was 64 Ϯ 15 years.
In the cohort, 113,605 patients (59%) met none of the guideline goals; 58,949 (31%) met one guideline goal; 16,641 (9%) met two guideline goals; and 3112 (1.6%) met all three guideline goals at hemodialysis initiation. Specifically, 18% of patients met the vascular access guideline goal, 26% the hemoglobin guideline goal, and 9% the albumin guideline goal.
Meeting Guideline Goals at Initiation by Pre-ESRD Nephrology Care
Among the included patients, 32% received no predialysis nephrology care, 35% received predialysis nephrology care for 12 months or less, and 22% received predialysis nephrology care for more than 12 months; predialysis nephrology care was not reported for 12%. Number of KDOQI guidelines goals met at dialysis initiation increased with presence and duration of predialysis nephrology care ( Table 2 ). Of patients who received predialysis nephrology care for more than 12 months, 43% met zero, 37% met one, 16% met two, and 4% met all three goals at dialysis initiation. Predialysis dietitian care was related to nephrology care; 0.3% of patients without nephrology care received dietitian care, as did 16% of patients with nephrology care for 12 months or less and 18% of patients with nephrology care for more than 12 months (Table 2) .
Independent Correlates of Meeting Individual Guideline Goals
Female sex, presence of most comorbid conditions, and functional status limitations were associated with lower frequency of meeting individual guideline goals (Table 3) . Conversely, employment at dialysis initiation was associated with higher frequency of meeting all of the individual goals. African American race was associated with higher likelihood of starting dialysis with an AV fistula or AV graft, but lower likelihood of meeting the hemoglobin and albumin guideline goals. Older age was associated with better dialysis access and meeting the hemoglobin guideline goal. Hypertension and glomerulonephritis as causes of ESRD were independently associated with greater likelihood of meeting the hemoglobin and albumin guideline goals at dialysis initiation, compared with diabetes as cause of ESRD. History of cerebrovascular accident was associated with a 9% increased likelihood of hemoglobin Ն 11 g/dl. Predialysis nephrology care was independently associated, in a graded manner, with increased likelihood of meeting all of the individual guideline goals (Table 3) .
First Year Survival by Number of KDOQI Guideline Goals Met at Dialysis Initiation
During follow-up, 47,809 patients (25%) died; 2957 (1.5%) were censored because of dialysis modality change, 3502 (1.8%) because of kidney transplant, and 4387 (2.3%) because of discontinuing dialysis due to restored kidney function. Unadjusted patient survival by number of KDOQI guideline goals met at dialysis initiation is presented in Figure 1 . Survival at 1 year was 71%, 76%, 86%, and 91% when zero, one, two, and three guideline goals were met, respectively, (P Ͻ 0.001). A survival benefit was associated with meeting all individual guideline goals (Figures 2 through 4 ). Survival at 1 year was 81%, 77%, and 70% for patients who received predialysis nephrology care for more than 12 months, for 12 months or less, and not at all, respectively (P Ͻ 0.001).
In multivariable analysis, a greater number of guideline goals met at dialysis initiation was independently associated with lower mortality during the first year of dialysis. Compared with meeting none of the guideline goals, meeting one, two, or three goals was each independently associated with lower first-year mortality rates: Adjusted hazards ratios (95% confidence interval) for death were 0.81 (0.80 to 0.83) for one goal, 0.53 (0.51 to 0.56) for two goals, and 0.34 (0.30 to 0.39) for three goals met (Table 4) . Meeting each of the individual guideline goals was also independently associated with survival benefit after adjusting for multiple covariates including meeting the other two goals (Table 4) . Predialysis nephrology care was also independently associated, in a graded manner, with survival benefit after multivariable adjustments including meeting each of the individual guideline goals: Adjusted hazards ratios (95% confidence interval) for death were 0.82 (0.80 to 0.84) for nephrology care for 12 months or less and 0.73 (0.70 to 0.75) for nephrology care for more than 12 months compared with no nephrology care.
Discussion
Meeting KDOQI guideline-recommended goals for vascular access, anemia, and serum albumin at dialysis initiation, individually and cumulatively, was independently associated with significantly lower mortality during the first year of dialysis.
Different patient characteristics were independently associated with meeting individual guideline goals at dialysis initiation. Despite regular access to medical care, institutionalized patients were less likely to meet the goals. This might be explained by a high burden of disease in this patient population. We also found racial and gender disparities. Women were less likely than men to meet all of the three guideline goals. Our study confirms findings by other investigators that women are underrepresented among hemodialysis patients with AV fistulas (8, 9) . This difference may be attributable to smaller vascular diameter and higher rates of early primary fistula failure among female patients (10) . Albumin and hemoglobin are also reported to be lower in women at dialysis initiation (11) . In the general population, hemoglobin is lower in women than in men (12) ; the etiology of lower albumin in women is less clear. African American patients were also less likely to meet hemoglobin and albumin goals. Other investigators have reported that African Americans start dialysis with lower levels of hemoglobin and albumin (13) , and require higher doses of erythropoietin to maintain hemoglobin at goal (14) . The lower hemoglobin at dialysis initiation has been attributed to lower predialysis use of erythropoietin (13) and higher prevalence of the thalassemia gene (15) in African Americans.
Racial and gender disparities in anemia and nutritional parameters are difficult to modify. The CMS ESRD quality improvement efforts for dialysis patients resulted in decreased disparity in adequacy of hemodialysis dose, but not in anemia and nutritional management (16). These disparities might be the result of biologic differences as well as differences in access to care, quality of care, patient knowledge, health beliefs, and clinician bias (17) . Regardless of the cause, these findings indicate a need to target interventions aimed at improved preparation for renal replacement therapy toward women and African Americans with advanced CKD.
Ours is the first study to report that African Americans are more likely than whites to initiate hemodialysis with AV fistulas or grafts. Other studies did not report association of race/ ethnicity with vascular access (8) or reported that African All P values for Chi-square test are Ͻ 0.0001.
American dialysis patients were less likely to use a catheter and more likely to use an AV graft compared with white patients (18) . One might speculate that African Americans are more likely to live in large urban centers with good access to vascular surgery services. The low frequency of patients meeting KDOQI guideline goals at dialysis initiation suggests opportunity for improvement. In our cohort, 18% of patients started dialysis with AV fistulas or grafts, 26% with hemoglobin Ն 11 g/dl, and 9.2% with albumin at goal. The proportions of patients who met guideline goals were much lower than reported for incident patients who survived on dialysis for at least 4 to 6 months (5,6). Among incident participants in the international Dialysis Outcomes and Practice Patterns Study, 29.7% started dialysis with AV fistulas or grafts, hemoglobin was Ն11 g/dl for 41%, and albumin was Ն3.5 g/dl for 60% (19) . Because over 95% of incident hemodialysis patients who initiated dialysis between June 2005 and May 2007 in the US were included in our cohort, the numbers reported in this study accurately reflect the far less than optimal state of dialysis preparedness in the US.
Our findings are in agreement with findings from previous investigations that reported that achieving clinical performance targets for hemoglobin and serum albumin and using fistulas for vascular access were associated with reduced deaths among RR, relative risk. a The logistic regression method was used to assess associations of meeting the individual guideline goals at dialysis initiation.
b Ն4.0 g/dl when the method of measurement was bromcresol green or unspecified or Ն3.7g/dl when the method of measurement was bromcresol purple.
c Also adjusted for history of hypertension, diabetes, cancer, chronic obstructive pulmonary disease, inability to ambulate and transfer, smoking, alcohol use, drug use, dietitian follow-up, and insurance at dialysis initiation. dialysis patients (4 -6) . While previous studies included prevalent dialysis patients or those who survived on dialysis for at least 4 to 6 months, our follow-up began at dialysis initiation, and our results suggest that meeting guideline goals at initiation is associated with greater survival during the first year of dialysis, when the risk of mortality is highest. Current evidence suggests that after dialysis initiation, the proportion of patients who meet guideline goals increases (6) . Average time to target hemoglobin for dialysis patients is only 1.3 months (14) . Therefore, values obtained after 4 to 6 months on dialysis are more likely to reflect a homogenous protocol-based approach to treatment practiced by dialysis facilities rather than more variable predialysis care. Patients receiving in-center hemodialysis receive regular medical care that provides most interventions. Before CKD patients begin dialysis, access to care and quality of care is widely variable. To date, a large effort has been made to improve the quality of care provided to patients on renal replacement therapy, with resultant improvement in prevalent patient outcomes (20) . Unfortunately, there is much less emphasis on improving predialysis care. Findings from our study underscore the need to identify measures to decrease variability and improve quality of predialysis care.
We found a graded survival benefit associated with longer duration of predialysis nephrology care. While prior studies defined "early referral" as 3 to 6 months before dialysis initiation (21-25), we found that nephrology care for more than 12 months, compared with less than 12 months, is associated with greater likelihood of meeting evidence-based guideline goals and improved survival during the first year of dialysis. Optimal duration of predialysis nephrology care remains to be determined. Of particular concern, even among patients who received nephrology care for more than 12 months, KDOQI guideline adherence was alarmingly low: 43% met zero, 37% met one, 16% met two, and only 4% met all three KDOQI guideline goals at dialysis initiation. Our study reveals extensive opportunity for improvement in patient care provided by nephrologists. Further research is needed, focusing on defining barriers to adequate postreferral care and on developing interventions aimed at improving the quality of postreferral care. Potential interventions may include use of case managers and multidisciplinary clinics to improve attainment of clinical performance measures in patients with CKD who are likely to need dialysis. This study was performed in a large national cohort of incident dialysis patients. The study period followed the widespread implementation of KDOQI guidelines and provides current information. Despite its strengths, this study has several limitations inherent in observational studies. Causality cannot be inferred. More severe illness, unidentified comorbidity, acuity, or noncompliance might explain some of the poor outcomes among patients who did not meet guideline goals at initiation. Despite adjustment for multiple covariates known to be associated with outcomes in dialysis patients, residual bias due to unmeasured confounders likely remains. The finding of an association between meeting the hemoglobin goal of Ն11 g/dl at dialysis initiation and better survival should be interpreted with caution. We chose targets recommended by the KDOQI guidelines at the time of care for the patient cohort to define guideline goal attainment. Several recent trials revealed no survival advantage and evidence of harm from efforts to achieve higher hemoglobin levels in patients with CKD (26 -28) . In our cohort, 7006 (12.3%) patients who were treated with erythropoietin before dialysis initiation had hemoglobin levels Ͼ12 g/dl. We used meeting the hemoglobin goal as the best surrogate for quality of predialysis medical care. In addition, our data were limited by a single measurement of laboratory values used to define guideline goal achievement, and methods for obtaining the values were not standardized. No data on control of bone metabolism parameters were available for analysis. Missing data were interpreted as not meeting the guideline goal. Furthermore, nephrology and dietitian care, as reported by patients' physicians on the Medical Evidence Report (form CMS-2728), was used in our models and in previous publications, but not validated (21).
In conclusion, this study suggests a graded association between meeting evidence-based guideline goals at initiation of dialysis and lower mortality during the first year of dialysis. We also report alarmingly poor guideline goal attainment at dialysis initiation in the US, even among patients seeing a nephrologist. Clinical practices associated with meeting evidence-based guideline goals before dialysis initiation should be identified and implemented to improve early patient outcomes on dialysis. a Cox proportional hazards models adjusted for age, sex, race, body mass index, smoking, alcohol use, drug dependence, cause of end-stage renal disease, functional status (inability to ambulate or transfer, assistance with activities of daily living, institutionalization, employment at the time of end-stage renal disease onset), comorbid conditions (history of atherosclerotic heart disease, congestive heart failure, cerebrovascular accident, peripheral vascular disease, hypertension, diabetes, chronic obstructive pulmonary disease, cancer), and predialysis nephrology and dietitian care.
b Cox proportional hazards models adjusted for the above variables with arteriovenous fistula or graft used at initiation, hemoglobin Ͼ 11 g/dl, and albumin at goal replacing the "number of guidelines achieved at initiation" variable.
c Goal: Hemoglobin Ͼ 11 g/dl. d Goal: Albumin Ն 4.0 g/dl when the method of measurement was bromcresol green or unspecified or Ն3.7 g/dl when the method of measurement was bromcresol purple.
